Dynamic contrast-enhanced MR imaging curve-type analysis: Is it helpful in the differentiation of prostate cancer from healthy peripheral zone? - Abstract

Purpose: To evaluate the performance and interobserver agreement of qualitative dynamic contrast material-enhanced magnetic resonance (MR) imaging curve analysis as described in the Prostate Imaging Reporting and Data System (PI-RADS) for the differentiation of prostate cancer (PCa) from healthy prostatic tissue in the peripheral zone (PZ).

Materials and Methods: This Health Insurance Portability and Accountability Act-compliant institutional review board-approved retrospective analysis included 120 consecutive pretreatment dynamic contrast-enhanced (DCE) MR imaging PCa examinations. Regions of interest (ROIs) were placed in 251 spots, including 95 (37.8%) in healthy PZ tissue and 156 (62.2%) in PCa, by using detailed histologic-multiparametric MR correlation review. Three radiologists reviewed the DCE time curves and assessed qualitative curve types as described in PI-RADS: type 1 (progressive), type 2 (plateau), or type 3 (washout). Receiver operating characteristic curve analysis was used to assess accuracy in differentiating PCa from healthy tissue on the basis of curve type, and κ was calculated to assess interobserver agreement.

Results: Receiver operating characteristic curves were similar for all observers, but mean areas under the receiver operating characteristic curve were poor (0.58 ± 0.04 [standard deviation] to 0.63 ± 0.04). No differences in accuracy were seen for varying DCE time resolution and imaging length. Observer agreement in assessment of type 3 versus types 1 or 2 curves was substantial (0.66 < κ < 0.79), better for PCa ROIs than for healthy-tissue ROIs. The agreement between type 1 and type 2 curves was moderate to substantial (0.49 < κ < 0.78).

Conclusion: Qualitative DCE MR imaging time-curve-type analysis performs poorly for differentiation of PCa from healthy prostatic tissue. Interobserver agreement is excellent in assessment of type 3 curves but only moderate for type 1 and 2 curves.

Written by:
Hansford BG, Peng Y, Jiang Y, Vannier MW, Antic T, Thomas S, McCann S, Oto A.   Are you the author?
Departments of Radiology and Pathology, University of Chicago Medical Center, 5841 S Maryland Ave, MC 526, Chicago, IL 60637; School of Electronic and Information Engineering, Beijing Jiaotong University, Beijing, China.

Reference: Radiology. 2015 Jan 5:140847.
doi: 10.1148/radiol.14140847

PubMed Abstract
PMID: 25559231

UroToday.com Prostate Cancer Section